Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Toxic protein assemblies found to play beneficial role in muscle generation

Toxic protein assemblies, or "amyloids," long considered to be key drivers in many neuromuscular diseases, also play a beneficial role in the development of healthy muscle tissue, University of Colorado Boulder researchers have found.

1 Nov 2018

Alzheimer's Association's Part the Cloud program funds innovative research on brain cells

Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.

31 Oct 2018

Genetic defect linked to ALS causes sugar-starved cells to overproduce lipids

A genetic defect tied to a variety of neurodegenerative diseases and mental illnesses changes how cells starved of sugar metabolize fatty compounds known as lipids, a new study led by researchers from the Johns Hopkins Bloomberg School of Public Health shows.

31 Oct 2018

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its research in AI for drug discovery at BioCentury China HealthCare Summit in Shanghai, 13-14 of November.

31 Oct 2018

FDA approves ultra-high-field 7T Terra MRI scanner for clinical use

The ultra-high-field 7T Terra magnetic resonance imaging scanner at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute of the Keck School of Medicine of USC has received FDA approval for clinical use, opening up new avenues of care for patients with Alzheimer's disease, multiple sclerosis and other diseases that affect the brain.

31 Oct 2018

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Nanoparticles that could reprogram a cancer patient's immune system inside their own body. Understanding a mysterious type of brain cell in the hopes of shedding new light on Alzheimer's disease. Reimagining nuclei, the DNA-storage compartments of our cells, as miniature lava lamps.

30 Oct 2018

UTHealth's Valentin Dragoi wins $1.6 million NIH award to unlock mysteries of the brain

Working to further the understanding of how the brain processes information, Valentin Dragoi, Ph.D., of The University of Texas Health Science Center at Houston has been awarded a three-year, $1.6 million award from the National Institutes of Health's Brain Research through Advancing Innovative Neurotechnologies Initiative.

30 Oct 2018

Insilico to present latest research on biomarkers at Investing in the Age of Longevity Conference

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest advances in human aging biomarker development at the Investing in the Age of Longevity Conference in London, 1 of November.

30 Oct 2018

Exercise could reduce risk of falling for older adults with AD

Alzheimer's disease is a brain disease that causes changes that kill brain cells. AD is a type of dementia, which causes memory loss and problems with thinking and making decisions.

29 Oct 2018

Neuroene Therapeutics receives $1.5 million NIH grant to develop anti-seizure compound for epilepsy

Neuroene Therapeutics, a start-up company founded by mitochondrial biologist Sherine S. L. Chan, Ph.D. and medicinal chemist C. James Chou, Ph.D. of the Medical University of South Carolina, has received a $1.5 million NIH Phase II Small Business Innovation Research grant to optimize vitamin K analogues that could improve seizure control in patients with drug-resistant epilepsy.

29 Oct 2018

Organ-on-a-chip model helps explore underlying pathways shared by stroke and dementia

Stroke is the second main cause of death globally, and a major cause of disability. Around 15 million people worldwide suffer a stroke each year, and rates are climbing, with the number of strokes in Europe set to increase by 1.5 million per year by 2025 – due in large part to the aging population.

29 Oct 2018

Studies show that non-invasive imaging can detect Alzheimer's disease

Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer's disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer's.

29 Oct 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

29 Oct 2018

Study finds weaker relationship between what older adults see and their brain activity

Forgetfulness and age-related memory lapses are a common complaint for many older adults, but what is still not understood is what causes these changes.

26 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Toxic protein assemblies found to play beneficial role in muscle generation

Alzheimer's Association's Part the Cloud program funds innovative research on brain cells

Genetic defect linked to ALS causes sugar-starved cells to overproduce lipids

Insilico to present its research in AI for drug discovery at BioCentury China HealthCare Summit

FDA approves ultra-high-field 7T Terra MRI scanner for clinical use

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

UTHealth's Valentin Dragoi wins $1.6 million NIH award to unlock mysteries of the brain

Insilico to present latest research on biomarkers at Investing in the Age of Longevity Conference

Exercise could reduce risk of falling for older adults with AD

Neuroene Therapeutics receives $1.5 million NIH grant to develop anti-seizure compound for epilepsy

Organ-on-a-chip model helps explore underlying pathways shared by stroke and dementia

Studies show that non-invasive imaging can detect Alzheimer's disease

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Study finds weaker relationship between what older adults see and their brain activity

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Innovative supportive care model tackles burdensome symptoms, challenges of dementia

UTA social work professors use NIH grant to find ways for reducing caregiver stress

Good mental ability and grip strength may prevent or delay disability in older adults

Tooth loss linked to malnutrition risk in older adults

Innovation in neuroscience drug discovery - eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in